title: [Osteoporosis: prevention of bone loss and fractures].
authors.affiliation: Institut für Klinische Osteologie Gustav Pommer und Klinik Der Fürstenhof, Bad Pyrmont. iko_pyrmont@t-online.de
authors.forename: Michael
authors.initials: M
authors.lastname: Pfeifer
authors.forename: Bettina
authors.initials: B
authors.lastname: Begerow
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Pollähne
authors.forename: Helmut W
authors.initials: HW
authors.lastname: Minne
mesh_terms: D015502:Absorptiometry, Photon; D000368:Aged; D000369:Aged, 80 and over; D019386:Alendronate / Q000627:therapeutic use; D001851:Bone Diseases, Metabolic / Q000188:drug therapy / Q000517:prevention & control; D003937:Diagnosis, Differential; D015444:Exercise; D005260:Female; D050723:Fractures, Bone / Q000517:prevention & control*; D006620:Hip Fractures / Q000000981:diagnostic imaging / Q000517:prevention & control; D006801:Humans; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000150:complications / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000517:prevention & control / Q000628:therapy*; D015663:Osteoporosis, Postmenopausal; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use; D012307:Risk Factors; D016103:Spinal Fractures / Q000000981:diagnostic imaging / Q000517:prevention & control; D013997:Time Factors; D014057:Tomography, X-Ray Computed
chemical_list: D020849:Raloxifene Hydrochloride; D019386:Alendronate